Sara Tenti is a writer and content creator. She has ghostwritten the book 

 for CBD expert Jamie Wood and collaborates with London-based marketing consultancy Kurve. Sara has also co-developed the concept for an original TV series which has recently been optioned by an award-nominated animation studio.

People expect products and services that feel made for them

Personal Worlds

Amy E. Rothberg is a clinical professor of medicine in the division of metabolism, endocrinology, and diabetes and a professor of nutritional sciences in the School of Public Health at the University of Michigan. She is also the director of the University of Michigan Weight Management Program, a two-year intensive behavioral and lifestyle program in which patients undergo extensive baseline and interval phenotyping to identify the factors that predict successful and cost-effective long-term weight loss.

 is an obesity medicine physician at Massachusetts General Hospital and instructor of medicine at Harvard Medical School. She is the founder and president of the New England Obesity Society, an organization that aims to provide education and resources for clinicians in the New England area interested in treating obesity and associated metabolic diseases. Dr. Anekwe’s interests are in the areas of clinical nutrition, obesity medicine, non-surgical weight management, health policy, and community health outreach, with a focus on underserved communities.

 is a specialist in endocrinology, obesity, and metabolism and the spokesperson for the Endocrine Society.

United States

Health and Fitness

Forbes Health

World Health Organization

Interview with Professor Amy Rothberg conducted by the author

Reuters

Becker’s Hospital Review

CNBC

Bloomberg

Stock Analysis

Interview with Dr. Chika Anekwe conducted by the author

Goldman Sachs

JP Morgan

Hers

New York Times

Interview with Dr. Deena Gupta-Adimoolam conducted by the author

Science News

ScienceAlert

New York Post

World Economic Forum

Deloitte

Fierce Pharma

Financial Times

Nutritional Outlook

Body +Soul

McKinsey & Company

Verywell Health

Zepbound, pharmaceutical company Eli Lilly’s prescription medicine for weight loss, is changing the landscape of weight management. Its effectiveness has triggered a surge in demand against the backdrop of a worldwide obesity epidemic and a significant cultural shift in weight-loss conversations.

Cultivate

Living Well

Growth and Progression

Why Eli Lilly’s Zepbound entices the weight-loss market